Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Lymphoma Clinical Trial

Official title: Tissue Procurement For Hematolymphoid Conditions

Status Recruiting

Clinical Trial Summary

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Clinical Trial Description

OBJECTIVES:

• Provide source of patient tissue, blood, and body fluid samples for ongoing diagnostic, prognostic, or immune-monitoring studies.

• Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies.

• Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research.

• Address medical and legal issues, and protect participant and patient privacy and confidentiality.

• Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and surgeon or hematology/oncology staff, researcher, and protocol office to obtain appropriate specimens for researchers.

• Support young investigators to obtain pilot data for grant funding.

OUTLINE: Patients undergo tissue, blood, and body fluid collection during diagnostic or routine procedures for future correlative studies. Tissue samples may include, but are not limited to, lymph node or non-nodal biopsies, bone marrow biopsy and/or aspirate, blood and serum, and buccal swabs for germline DNA analysis. ;

Related Conditions & MeSH terms

• Chronic Myeloproliferative Disorders
• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Lymphoproliferative Disorders
• Multiple Myeloma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Myelodysplastic-Myeloproliferative Diseases
• Myelodysplastic/Myeloproliferative Neoplasms
• Myeloproliferative Disorders
• Neoplasms
• Neoplasms, Plasma Cell
• Nonmalignant Neoplasm
• Plasmacytoma
• Preleukemia
• Syndrome

• NCT number: NCT01137643
• Study type: Observational
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: Paul Armistead, MD
• Phone: (919) 843-6847
• Email: paul_armistead@med.unc.edu
• Status: Recruiting
• Start date: July 2009
• Completion date: July 2040